The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Vasenina E.E.

Russian Medical Academy of Continuous Professional Education

Imp of panic

Authors:

Vasenina E.E.

More about the authors

Journal: Non Nocere. New Therapeutic Journal. 2023;(8): 58‑62

Read: 562 times

Download PDF (RU)
Contact the author
Table of contents

To cite this article:

Vasenina EE. Imp of panic. Non Nocere. New Therapeutic Journal. 2023;(8):58‑62. (In Russ.)

 
ЭндоКард
 
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Abstract:

Anxiety in women: on the hormone swing.

Authors:

Vasenina E.E.

Russian Medical Academy of Continuous Professional Education

Close metadata

References:

  1. Andreescu C, Lee S. Anxiety Disorders in the Elderly. Adv Exp Med Biol. 2020;1191:561–576.  https://doi.org/10.1007/978-981-32-9705-0_28
  2. Premraj L, Kannapadi NV, Briggs J, Seal SM, Battaglini D, Fanning J, et al. Mid and long-term neurological and neuropsychiatric manifestations of post-COVID 19 syndrome: A meta-analysis. J Neurol Sci. 2022 Mar 15;434:120162. https://doi.org/10.1016/j.jns.2022.120162
  3. Glushchenko YaYu, Slavgorodskaya MS, Dmitriev MN. Affective disorders first emerged in the post-coital period: analysis of clinical cases. Chief physician of the South of Russia. 2023;1(87):33–37. 
  4. Vasenina E.E., Gankina O.A., Levin O.S. Anxiety disorders in clinical practice: from development mechanisms to differentiated therapy. Meditsinskiy sovet = Medical Council. 2023;(10):89–96. (In Russ.) https://doi.org/10.21518/ms2023-235
  5. Tang S, Graham BM. The Role of Hormonal and Reproductive Status in the Treatment of Anxiety Disorders in Women. Adv Exp Med Biol. 2020;1191:523–541.  https://doi.org/10.1007/978-981-32-9705-0_26
  6. Nakić Radoš S, Tadinac M, Herman R. Anxiety During Pregnancy and Postpartum: Course, Predictors and Comorbidity with Postpartum Depression. Acta Clin Croat. 2018 Mar;57(1):39–51.  https://doi.org/10.20471/acc.2017.56.04.05
  7. McHenry J, Carrier N, Hull E, Kabbaj M. Sex differences in anxiety and depression: role of testosterone. Front Neuroendocrinol. 2014 Jan;35(1):42–57.  https://doi.org/10.1016/j.yfrne.2013.09.001
  8. Chronister BN, Gonzalez E, Lopez-Paredes D, Suarez-Torres J, Gahagan S, Martinez D, et al. Testosterone, estradiol, DHEA and cortisol in relation to anxiety and depression scores in adolescents. J Affect Disord. 2021 Nov 1;294:838–846.  https://doi.org/10.1016/j.jad.2021.07.026
  9. Zitzmann M. Testosterone, mood, behaviour and quality of life. Andrology. 2020 Nov;8(6):1598–1605. https://doi.org/10.1111/andr.12867
  10. Pavlidi P, Kokras N, Dalla C. Antidepressants’ effects on testosterone and estrogens: What do we know? Eur J Pharmacol. 2021 May 15;899:173998. https://doi.org/10.1016/j.ejphar.2021.173998
  11. Rogers J. Androgen signal for brain size. Nat Rev Neurosci. 2022 Apr;23(4):188–189.  https://doi.org/10.1038/s41583–022–00571-y.
  12. Swaab DF, Wolff SEC, Bao AM. Sexual differentiation of the human hypothalamus: Relationship to gender identity and sexual orientation. Handb Clin Neurol. 2021;181:427–443.  https://doi.org/10.1016/B978-0-12-820683-6.00031-2
  13. Mhillaj E, Morgese MG, Tucci P, Bove M, Schiavone S, Trabace L. Effects of anabolic-androgens on brain reward function. Front Neurosci. 2015 Aug 26;9:295.  https://doi.org/10.3389/fnins.2015.00295
  14. Baik JH. Stress and the dopaminergic reward system. Exp Mol Med. 2020 Dec;52(12):1879–1890. https://doi.org/10.1038/s12276-020-00532-4
  15. Songtachalert T, Roomruangwong C, Carvalho AF, Bourin M, Maes M. Anxiety Disorders: Sex Differences in Serotonin and Tryptophan Metabolism. Curr Top Med Chem. 2018;18(19):1704–1715. https://doi.org/10.2174/1568026618666181115093136
  16. Kalinchenko SYu, Tyuzikov IA, Tishova YuA, Vorslov LO. Testosterone Functions in Women. General and Age-Specific Endocrine Functions of Testosterone in Women. Doctor.ru. Gynecology. Endocrinology. 2015;14(115):59–64. 
  17. Ellis MN, Wright MD, Dennis TS. Estradiol administration increases anxiety-like behavior following chronic escalating morphine administration in hormone-replaced ovariectomized female rats. Pharmacol Biochem Behav. 2023 Jun;227–228:173582. https://doi.org/10.1016/j.pbb.2023.173582
  18. Borrow AP, Handa RJ. Estrogen Receptors Modulation of Anxiety-Like Behavior. Vitam Horm. 2017;103:27–52.  https://doi.org/10.1016/bs.vh.2016.08.004
  19. Kalra B, Kalra S, Bhattacharya S, Dhingra A. Menopause distress: A person centered definition. J Pak Med Assoc. 2020 Dec;70(12(B)):2481–2483.
  20. Minkin MJ. Menopause: Hormones, Lifestyle, and Optimizing Aging. Obstet Gynecol Clin North Am. 2019 Sep;46(3):501–514.  https://doi.org/10.1016/j.ogc.2019.04.008
  21. Beking T, Burke SM, Geuze RH, Staphorsius AS, Bakker J, Groothuis AGG, Kreukels BPC. Testosterone effects on functional amygdala lateralization: A study in adolescent transgender boys and cisgender boys and girls. Psychoneuroendocrinology. 2020 Jan;111:104461. https://doi.org/10.1016/j.psyneuen.2019.104461
  22. Walf AA, Frye CA. A review and update of mechanisms of estrogen in the hippocampus and amygdala for anxiety and depression behavior. Neuropsychopharmacology. 2006 Jun;31(6):1097–1111. https://doi.org/10.1038/sj.npp.1301067
  23. Lee E, Anselmo M, Tahsin CT, Vanden Noven M, Stokes W, Carter JR, Keller-Ross ML. Vasomotor symptoms of menopause, autonomic dysfunction, and cardiovascular disease. Am J Physiol Heart Circ Physiol. 2022 Dec 1;323(6): H1270–H1280. https://doi.org/10.1152/ajpheart.00477.2022
  24. Poplavskaya OV, Tsybulia YuV. Modern approaches to the use of grandaxin (tofizopam) in the therapy of asthenic states. Drug Bulletin. 2017;1(65):32-37. 
  25. A tofizopam (Grandaxin) farmakológiai hatásai [Pharmacologic effects of tofizopam (Grandaxin)]. Acta Pharm Hung. 1993 Mar;63(2):79–82. Hungarian.
  26. Bond A, Lader M. A comparison of the psychotropic profiles of tofisopam and diazepam. Eur J Clin Pharmacol. 1982;22(2):137–142.  https://doi.org/10.1007/BF00542458
  27. Gribacheva IA, Zhukova NG. Vegetocorrecting and anxiolytic effect of tofizopam in the premenopausal period. Physician. 2010;5:52-57. 
  28. Strizhakov AN, Podzolkova NM, Glazkova OL, Romanova EN. Grandaxin as a possible alternative to hormone replacement therapy. Bulletin of the Russian Association of Obstetricians and Gynecologists. 2000;3:67-69. 
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.